These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 35413582)

  • 1. Coumarin derivatives as inhibitors of d-amino acid oxidase and monoamine oxidase.
    Bester E; Petzer A; Petzer JP
    Bioorg Chem; 2022 Jun; 123():105791. PubMed ID: 35413582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibition of monoamine oxidase by 2H-1,4-benzothiazin-3(4H)-ones.
    Hitge R; Petzer JP; Petzer A
    Bioorg Med Chem Lett; 2022 Dec; 77():129038. PubMed ID: 36307034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Coumaranone derivatives as inhibitors of monoamine oxidase.
    Van Dyk AS; Petzer JP; Petzer A; Legoabe LJ
    Drug Des Devel Ther; 2015; 9():5479-89. PubMed ID: 26491258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenothiazine, anthraquinone and related tricyclic derivatives as inhibitors of monoamine oxidase.
    Lefin R; Petzer A; Petzer JP
    Bioorg Med Chem; 2022 Jan; 54():116558. PubMed ID: 34915314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isatoic anhydrides as novel inhibitors of monoamine oxidase.
    Hitge R; Petzer A; Petzer JP
    Bioorg Med Chem; 2022 Nov; 73():117030. PubMed ID: 36179486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advancements and SAR Studies of Synthetic Coumarins as MAO-B Inhibitors: An Updated Review.
    Kaur P; Rangra NK
    Mini Rev Med Chem; 2024; 24(20):1834-1846. PubMed ID: 38778598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of pyrazolo[1,5-a]quinoxalin-4-ones as novel monoamine oxidase inhibitors.
    Panova VA; Filimonov SI; Chirkova ZV; Kabanova MV; Shetnev AA; Korsakov MK; Petzer A; Petzer JP; Suponitsky KY
    Bioorg Chem; 2021 Mar; 108():104563. PubMed ID: 33376014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine oxidase inhibition properties of 2,1-benzisoxazole derivatives.
    Shetnev A; Kotov A; Kunichkina A; Proskurina I; Baykov S; Korsakov M; Petzer A; Petzer JP
    Mol Divers; 2024 Jun; 28(3):1009-1021. PubMed ID: 36934384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of nitrocatechol chalcone and pyrazoline derivatives as inhibitors of catechol-O-methyltransferase and monoamine oxidase.
    Hitge R; Smit S; Petzer A; Petzer JP
    Bioorg Med Chem Lett; 2020 Jun; 30(12):127188. PubMed ID: 32299731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indanones as high-potency reversible inhibitors of monoamine oxidase.
    Mostert S; Petzer A; Petzer JP
    ChemMedChem; 2015 May; 10(5):862-73. PubMed ID: 25820651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evaluation of 1-tetralone and 4-chromanone derivatives as inhibitors of monoamine oxidase.
    Cloete SJ; N'Da CI; Legoabe LJ; Petzer A; Petzer JP
    Mol Divers; 2021 Feb; 25(1):491-507. PubMed ID: 32970293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel monoamine oxidase inhibitors based on the privileged 2-imidazoline molecular framework.
    Shetnev A; Osipyan A; Baykov S; Sapegin A; Chirkova Z; Korsakov M; Petzer A; Engelbrecht I; Petzer JP
    Bioorg Med Chem Lett; 2019 Jan; 29(1):40-46. PubMed ID: 30455149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrocatechol Derivatives of Chalcone as Inhibitors of Monoamine Oxidase and Catechol-O-Methyltransferase.
    Engelbrecht I; Petzer JP; Petzer A
    Cent Nerv Syst Agents Med Chem; 2018; 18(2):115-127. PubMed ID: 29697034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinolinic Carboxylic Acid Derivatives as Potential Multi-target Compounds for Neurodegeneration: Monoamine Oxidase and Cholinesterase Inhibition.
    Khan NA; Khan I; Abid SMA; Zaib S; Ibrar A; Andleeb H; Hameed S; Iqbal J
    Med Chem; 2018; 14(1):74-85. PubMed ID: 28545383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Evaluation of 2-benzylidene-1-tetralone Derivatives for Monoamine Oxidase Inhibitory Activity.
    Amakali KT; Legoabe LJ; Petzer A; Petzer JP
    Cent Nerv Syst Agents Med Chem; 2018; 18(2):136-149. PubMed ID: 29714148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of novel benzocoumarin derivatives as potent inhibitors of MAO-B activity.
    Meletli F; Gündüz C; Alparslan MM; Attar A; Demir S; İskit E; Danış Ö
    Bioorg Med Chem Lett; 2024 Nov; 113():129984. PubMed ID: 39384075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Selected Natural Compounds as Dual Inhibitors of Catechol-O-Methyltransferase and Monoamine Oxidase.
    Engelbrecht I; Petzer JP; Petzer A
    Cent Nerv Syst Agents Med Chem; 2019; 19(2):133-145. PubMed ID: 31258092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of 2-substituted 4(3H)-quinazolinone thioether derivatives as monoamine oxidase inhibitors.
    Qhobosheane MA; Petzer A; Petzer JP; Legoabe LJ
    Bioorg Med Chem; 2018 Nov; 26(20):5531-5537. PubMed ID: 30279044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the Molecular Determinant of Reversible Human Monoamine Oxidase B Inhibitors Containing 2H-Chromen-2-One Core: Structure-Based and Ligand-Based Derived Three-Dimensional Quantitative Structure-Activity Relationships Predictive Models.
    Mladenović M; Patsilinakos A; Pirolli A; Sabatino M; Ragno R
    J Chem Inf Model; 2017 Apr; 57(4):787-814. PubMed ID: 28291352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson's disease therapy.
    Rodríguez-Enríquez F; Costas-Lago MC; Besada P; Alonso-Pena M; Torres-Terán I; Viña D; Fontenla JÁ; Sturlese M; Moro S; Quezada E; Terán C
    Bioorg Chem; 2020 Nov; 104():104203. PubMed ID: 32932120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.